ES500185A0 - Un metodo para la preparacion de una formulacion farmaceutica de un antibiotico glicosidico o similar. - Google Patents

Un metodo para la preparacion de una formulacion farmaceutica de un antibiotico glicosidico o similar.

Info

Publication number
ES500185A0
ES500185A0 ES500185A ES500185A ES500185A0 ES 500185 A0 ES500185 A0 ES 500185A0 ES 500185 A ES500185 A ES 500185A ES 500185 A ES500185 A ES 500185A ES 500185 A0 ES500185 A0 ES 500185A0
Authority
ES
Spain
Prior art keywords
glycosidic
preparation
pharmaceutical formulation
antibiotics
hydroxyaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES500185A
Other languages
English (en)
Other versions
ES8301631A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Interx Research Corp
Original Assignee
Interx Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interx Research Corp filed Critical Interx Research Corp
Publication of ES500185A0 publication Critical patent/ES500185A0/es
Publication of ES8301631A1 publication Critical patent/ES8301631A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
ES500185A 1980-03-07 1981-03-06 Un metodo para la preparacion de una formulacion farmaceutica de un antibiotico glicosidico o similar. Expired ES8301631A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12810080A 1980-03-07 1980-03-07

Publications (2)

Publication Number Publication Date
ES500185A0 true ES500185A0 (es) 1983-01-01
ES8301631A1 ES8301631A1 (es) 1983-01-01

Family

ID=22433639

Family Applications (1)

Application Number Title Priority Date Filing Date
ES500185A Expired ES8301631A1 (es) 1980-03-07 1981-03-06 Un metodo para la preparacion de una formulacion farmaceutica de un antibiotico glicosidico o similar.

Country Status (13)

Country Link
EP (1) EP0035770B1 (es)
JP (1) JPS579725A (es)
AT (1) ATE24398T1 (es)
AU (1) AU545885B2 (es)
CA (1) CA1166962A (es)
DE (1) DE3175733D1 (es)
DK (1) DK102081A (es)
ES (1) ES8301631A1 (es)
GR (1) GR74443B (es)
IE (1) IE52397B1 (es)
NZ (1) NZ196348A (es)
PT (1) PT72592B (es)
ZA (1) ZA811514B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU541247B2 (en) * 1979-12-20 1985-01-03 R.P. Scherer Corporation Adjuvants for rectal delivery of drug substances
IT1189285B (it) * 1982-05-28 1988-02-04 Nuovo Consor Sanitar Nazionale Sali dell'antibiotico eritromicina e del suo estere propionico con acidi ad attivita' terapeutica coadiuvante
FR2557453B1 (fr) * 1983-12-29 1988-02-19 Virbac Ctre Rech Biolog Nouvelle propriete pharmacocinetique des aminoglucosides
PA8444901A1 (es) * 1997-01-28 2000-05-24 Hoffmann La Roche Derivados de 5-aroilnaftaleno como agentes anti-inflamatorios
DE102004017141A1 (de) * 2004-04-01 2005-12-01 Bergische Universität Wuppertal Neue Gene aus Biosynthese Genclustern zur Synthese von Aminoglycosid-Antibiotika sowie damit herstellbare neue Aminoglycosid-Antibiotika
US9018158B2 (en) * 2009-06-03 2015-04-28 Algipharma As Alginate oligomers for use in overcoming multidrug resistance in bacteria
CN105101950B (zh) * 2013-03-05 2019-10-11 安特里斯生物制药公司 口服递送的药物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3777018A (en) * 1967-03-31 1973-12-04 Schmid Inc Julius Compositions containing polyenic macro-lide and aryl derivative of aliphatic acid and method for treating hyper-lipidaemia
GB1559840A (en) * 1975-12-01 1980-01-30 Gist Brocades Nv Antifungal compositions
FR2379285A2 (fr) * 1977-02-08 1978-09-01 Expl Marques Brevets Et Nouvelle composition a base d'acide salicylique et de corticoide
US4268503A (en) * 1978-09-14 1981-05-19 Fujisawa Pharmaceutical Co., Ltd. Antibacterial composition

Also Published As

Publication number Publication date
IE810453L (en) 1981-09-07
NZ196348A (en) 1984-08-24
DE3175733D1 (en) 1987-02-05
EP0035770A2 (en) 1981-09-16
GR74443B (es) 1984-06-28
CA1166962A (en) 1984-05-08
JPS579725A (en) 1982-01-19
AU545885B2 (en) 1985-08-08
PT72592B (en) 1985-11-25
EP0035770A3 (en) 1981-09-23
ZA811514B (en) 1982-10-27
EP0035770B1 (en) 1986-12-30
ATE24398T1 (de) 1987-01-15
ES8301631A1 (es) 1983-01-01
PT72592A (en) 1981-03-01
AU6805681A (en) 1981-09-10
DK102081A (da) 1981-09-08
IE52397B1 (en) 1987-10-14

Similar Documents

Publication Publication Date Title
ES500186A0 (es) Un metodo, para la preparacion de una formulacion farmaceutica de un agente bioactivo polar.
SE8504945L (sv) Farmaceutiska kompositioner innehallande antracyklinglykosider
YU92192A (sr) Postupak za dobijanje preparata soli lipofilnih oligosaharidnih antibiotika
PT86913A (pt) Processo de preparacao de sistemas droga-lipido de baixa toxicidade
BR9401199A (pt) Preparados de medicamentos, processo para a preparação de um preparado de medicamento, processo para a preparação de uma formulação de medicamento.
BR9814498A (pt) Processo para o tratamento de obesidade em um humano necessitando de tal tratamento, composto, uso do mesmo, produto, e, composição farmacêutica
ES500185A0 (es) Un metodo para la preparacion de una formulacion farmaceutica de un antibiotico glicosidico o similar.
ES500184A0 (es) Un metodo para la preparacion de una formulacion farmaceutica de antibioticos de b-lactama.
IE40957L (en) 4- o-ó,d-glucopyranosyl -6-o-ó,d- xylohexopyranosyl -2-¹deoxystreptamine
IE43125L (en) Aminoglycoside derivative
DE59510583D1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
EE02938B1 (et) p-hüdroksübensoehappe derivaadid, nende valmistamismeetod ja kasutamine ravimitena

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970303